OpenAI's Fidji Simo steps down to focus on chronic illness recovery
Fidji Simo has stepped down from her full-time role as OpenAI's president of applications, transitioning to a part-time advisory position to focus on her health. The decision comes after a three-month medical leave due to a severe exacerbation of a chronic illness she has managed for seven years. Simo expressed regret for not prioritizing her health sooner and thanked OpenAI's leadership for their support during her recovery.

*this image is generated using AI for illustrative purposes only.
Fidji Simo stepped down from her full-time role as OpenAI's president of applications on Thursday, transitioning to a part-time advisory position to prioritize her recovery from a chronic illness. Simo, who took medical leave three months ago, stated that her recovery has taken longer than anticipated. In a post on X, she explained that she is only making this decision now because she "failed to make it many times before." The move marks a significant shift in leadership at the artificial intelligence company, where Simo reported directly to CEO Sam Altman.
Simo disclosed that she experienced a "severe exacerbation" of a chronic illness she has lived with for seven years. She reflected on her history of prioritizing work over health, recalling a time when she declined a full year of medical leave offered by Meta. During that period, Meta CEO Mark Zuckerberg had advised her to "play the long game." Simo's recent medical leave in April prompted a leadership shuffle at OpenAI, with Greg Brockman overseeing product and Brad Lightcap transitioning to special projects.
Leadership Transition and Support
Simo's departure from the full-time role follows a series of senior executive exits at OpenAI this year. Despite the reduction in her responsibilities, Simo remains committed to the company's mission. She thanked Altman, President Brockman, and the board for their support during her medical leave. Simo also indicated that she will continue to work toward disease cures through her involvement with OpenAI, Chronicle BioAI, and CODA Research.
Rishi N. Reddy, a colleague and co-founder, publicly responded to Simo's announcement, praising her decision to prioritize her health. Reddy described Simo as "an n of 1" and emphasized that knowing when to step back can be more difficult than continuing to push forward. He expressed confidence that she would emerge stronger and continue to make an impact.
Background at OpenAI
OpenAI appointed Simo to the newly created role of chief of applications in May 2025. At the time of her appointment, she was the CEO of Instacart. Her transition to a part-time advisor role concludes her tenure as a key executive driving OpenAI's application strategy. The company has yet to announce a permanent replacement for her full-time responsibilities.
Who will OpenAI appoint to fill the permanent leadership void left by Simo's departure?
How will Simo's reduced role impact the timeline and strategy for OpenAI's application development?
Will this leadership transition trigger further executive reshuffling within OpenAI's product teams?

































